Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03642938 · ClinicalTrials.gov registry record · NA

Exercise Dosing for Pain in Healthy Participants

A NA study of Pain, sponsored by Duquesne University.

Completed
Registry status
NA
Development phase
41
Enrollment target
1
Study location

NCT03642938 is a NA study of Pain that has completed, run by Duquesne University. The registered enrollment target is 41 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03642938, a NA study of Pain, has completed, sponsored by Duquesne University.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

In this study investigators will examine the effect of dose related to exercise therapy for pain in healthy adult humans. An acute pain model will be employed to study the effect of exercise dose on pain. Acute pain models are currently used to study pain (both acute and chronic) in human samples as there is currently no chronic pain model.

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Walking Exercise

Study Locations (1)

Pennsylvania

  • Duquesne University - Pittsburgh

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2015-02-11
Est. Completion 2017-06-06
Phase NA

Sponsor

Duquesne University

21 total trials

What the Registry Record Tells You About NCT03642938

The ClinicalTrials.gov registry entry for NCT03642938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower). The listed sponsor is Duquesne University, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT03642938 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03642938 about?

NCT03642938 is a clinical study titled "Exercise Dosing for Pain in Healthy Participants". In this study investigators will examine the effect of dose related to exercise therapy for pain in healthy adult humans. An acute pain model will be employed to study the effect of exercise dose on pain. Acute pain models are currently used to study pain (both acute and chronic) in human samples as...

What is the current status of trial NCT03642938?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-02-11. Estimated completion is 2017-06-06.

What conditions does trial NCT03642938 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT03642938?

The interventions under investigation include: Control (BEHAVIORAL), Walking Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03642938?

This trial is sponsored by Duquesne University, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03642938 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.